COMPARISON OF THE OPSONIC AND COMPLEMENT ACTIVATING ACTIVITY OF HUMAN MONOCLONAL IGG AND IGM ANTIBODY AGAINST GROUP-B STREPTOCOCCI

被引：0
|
作者：
SHYU, SD
RAFF, HV
BOHNSACK, JF
KELSEY, DK
HILL, HR
机构：
[1] UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112
[3] MEAD JOHNSON RES CTR,EVANSVILLE,IN
来源：
PEDIATRIC RESEARCH | 1991年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A185 / A185
页数：1
相关论文
共 50 条
  • [31] THE PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST STREPTOCOCCI OF THE SEROLOGIC GROUP-B TYPE-III
    MULLER, WA
    BORKHARDT, HL
    SCHUSTER, G
    HERRMANN, M
    LAUF, H
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1986, 41 (05): : 373 - 376
  • [32] INTRAVENOUS ADMINISTRATION OF HUMAN-IGG TO NEWBORN-INFANTS - CHANGES IN SERUM ANTIBODY-LEVELS TO GROUP-B STREPTOCOCCI
    CHRISTENSEN, KK
    CHRISTENSEN, P
    BUCHER, HU
    DUC, G
    KIND, CH
    MIETH, D
    MULLER, B
    SEGER, RA
    EUROPEAN JOURNAL OF PEDIATRICS, 1984, 143 (02) : 123 - 127
  • [33] COMPLEMENT AND ANTIBODY PARTICIPATION IN OPSONOPHAGOCYTOSIS OF TYPE-IV AND TYPE-V GROUP-B STREPTOCOCCI
    HALL, MA
    EDWARDS, MS
    BAKER, CJ
    INFECTION AND IMMUNITY, 1992, 60 (12) : 5030 - 5035
  • [34] Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis
    Han, YM
    Kozel, TR
    Zhang, MX
    MacGill, RS
    Carroll, MC
    Cutler, JE
    JOURNAL OF IMMUNOLOGY, 2001, 167 (03): : 1550 - 1557
  • [35] COMPARATIVE INVITRO BACTERICIDAL ACTIVITY OF CEFONICID, CEFTIZOXIME, AND PENICILLIN AGAINST GROUP-B STREPTOCOCCI
    BAYER, AS
    MORRISON, JO
    KIM, KS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) : 344 - 346
  • [36] ACTIVITY OF PENICILLIN COMBINED WITH AN AMINOGLYCOSIDE AGAINST GROUP-B STREPTOCOCCI INVITRO AND IN EXPERIMENTAL ENDOCARDITIS
    BACKES, RJ
    ROUSE, MS
    HENRY, NK
    GERACI, JE
    WILSON, WR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (04) : 491 - 498
  • [37] ACTIVITY OF MOXALACTAM AND CEFOTAXIME ALONE AND IN COMBINATION WITH AMPICILLIN OR PENICILLIN AGAINST GROUP-B STREPTOCOCCI
    LANDESMAN, SH
    CORRADO, ML
    CHERUBIN, CE
    SIERRA, MF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (05) : 794 - 797
  • [38] AMNIOTIC-FLUID ACTIVITY AGAINST BACTEROIDES-FRAGILIS AND GROUP-B STREPTOCOCCI
    EVALDSON, G
    NORD, CE
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1981, 170 (01) : 11 - 17
  • [39] DEVELOPMENT OF IGM ANTIBODY TO GROUP-B STREPTOCOCCUS TYPE-III IN HUMAN INFANTS
    BOYER, KM
    KLEGERMAN, ME
    GOTOFF, SP
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06): : 1049 - 1055
  • [40] DEMONSTRATION OF OPSONIC ACTIVITY AND INVIVO PROTECTION AGAINST GROUP-B STREPTOCOCCI TYPE-III BY STREPTOCOCCUS-PNEUMONIAE TYPE-14 ANTISERA
    FISCHER, GW
    LOWELL, GH
    CRUMRINE, MH
    BASS, JW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (03): : 776 - 786
12345